Publication Author: Sullivan_Sean
-
The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review.
Woo L, Smith HE, Sullivan SD. The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review. Value Health Reg Issues. 2019 May;18:121-131. doi: 10.1016/j.vhri.2019.02.002. Epub 2019 Apr 30.
rakerr2
-
Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure Models.
Bansal A, Sullivan SD, Lin VW, Purdum AG, Navale L, Cheng P, Ramsey SD. Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure
rakerr2
-
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States.
Roth JA, Sullivan SD, Lin VW, Bansal A, Purdum AG, Navale L, Cheng P, Ramsey SD. Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States. J Med Econ. 2018 Oct 16:1-8. doi: 10.
rakerr2
-
Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.
McDermott CL, Bansal A, Ramsey SD, Lyman GH, Sullivan SD. Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer. J Pain Symptom Manage. 2018 Nov;56(5):699-708.e1. doi: 10.1016/j.jpainsymman.2018.
rakerr2
-
Price elasticities of pharmaceuticals in a value based-formulary setting.
Yeung K, Basu A, Hansen RN, Sullivan SD. Price elasticities of pharmaceuticals in a value based-formulary setting. Health Econ. 2018 Jul 20. doi: 10.1002/hec.3801. [Epub ahead of print]
rakerr2
-
Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes.
Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 Jul;56(7):583-588. doi: 10.1097/MLR.0000000000000924.
rakerr2
-
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Sullivan SD, Bailey TS, Roussel R, Zhou FL, Bosnyak Z, Preblick R, Westerbacka J, Gupta RA, Blonde L. Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectivene
rakerr2
-
Association Between the Publication of Clinical Evidence and the Use of Bariatric Surgery.
Kim DD, Arterburn DE, Sullivan SD, Basu A. Association Between the Publication of Clinical Evidence and the Use of Bariatric Surgery. Obes Surg. 2018 May;28(5):1321-1328. doi: 10.1007/s11695-017-2990-1.
rakerr2
-
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.
Olchanski N, Hansen RN, Pope E, D’Cruz B, Fergie J, Goldstein M, Krilov LR, McLaurin KK, Nabrit-Stephens B, Oster G, Schaecher K, Shaya FT, Neumann PJ, Sullivan SD. Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Val
rakerr2
-
Returns to scientific publications for pharmaceutical products in the United States.
Slejko JF, Basu A, Sullivan SD. Returns to scientific publications for pharmaceutical products in the United States. Health Econ. 2017 Jul 10. doi: 10.1002/hec.3546. [Epub ahead of print]
rakerr2